Literature DB >> 15108274

DNA analysis by MALDI-TOF mass spectrometry.

Ivo Glynne Gut1.   

Abstract

The last decade has seen an increased demand for high-throughput DNA analysis. This is mainly due to the human genome sequencing project that is now completed. Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry was pinpointed early on as a technology that could be of great use for sequence variation analysis in the post-genome sequencing era. Applications developed first on this platform were for SNP genotyping. Several strategies for allele-discrimination (hybridization, cleavage, ligation, and primer extension) were combined with MALDI-TOF mass spectrometric detection. Nowadays, in practice, only primer extension methods are applied for large-scale SNP genotyping studies with MALDI-TOF detection. Problems surrounding the integration of SNP genotyping by MALDI-TOF mass spectrometry at high throughput are largely mastered now. Mass spectrometry geared presentations at the HUGO Mutation Detection Meeting in Palm Cove, Australia almost exclusively focused on novel applications that go beyond standard SNP genotyping. These applications are more demanding in terms of chemistry and molecular biology. Molecular haplotyping, expression profiling, DNA methylation analysis, and mutation detection are now being demonstrated. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15108274     DOI: 10.1002/humu.20023

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  15 in total

Review 1.  Epigenetic mechanisms in developmental programming of adult disease.

Authors:  Man Chen; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-16       Impact factor: 7.851

2.  Simultaneous determination of multiple mRNA levels utilizing MALDI-TOF mass spectrometry and biotinylated dideoxynucleotides.

Authors:  Daniel Scott Duffield; Li Cai; Sobin Kim
Journal:  RNA       Date:  2010-04-21       Impact factor: 4.942

3.  Technologies in the Whole-Genome Age: MALDI-TOF-Based Genotyping.

Authors:  Nicolas Vogel; Katrin Schiebel; Andreas Humeny
Journal:  Transfus Med Hemother       Date:  2009-07-10       Impact factor: 3.747

4.  High-throughput homogeneous mass cleave assay technology for the diagnosis of autosomal recessive Parkinson's disease.

Authors:  Christopher Schroeder; Michael Walter; Daniela Berg; Petra Leitner; Peter Bauer; Zacharias Kohl; Jürgen Winkler; Olaf Riess; Michael Bonin
Journal:  J Mol Diagn       Date:  2008-04-10       Impact factor: 5.568

5.  Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

Authors:  Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Liying Yan; Mami Cantor; Chungdak Namgyal; Mari Mino-Kenudson; Gregory Y Lauwers; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

6.  Novel pathway analysis of genomic polymorphism-cancer risk interaction in the Breast Cancer Prevention Trial.

Authors:  Barbara K Dunn; Mark H Greene; Jenny M Kelley; Joseph P Costantino; Robert J Clifford; Ying Hu; Gong Tang; Neely Kazerouni; Philip S Rosenberg; Daoud M Meerzaman; Kenneth H Buetow
Journal:  Int J Mol Epidemiol Genet       Date:  2010-09-05

7.  Somatic mutation in synchronous primary adenocarcinomas of the left lung: a case report.

Authors:  Xiaoli Yu; Danli Sheng; Junchang Jiang; Minpu Ren; Mei Jin; Songxiao Xu
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

8.  Negative Ion MALDI Mass Spectrometry of Polyoxometalates (POMs): Mechanism of Singly Charged Anion Formation and Chemical Properties Evaluation.

Authors:  Jean E Boulicault; Sandra Alves; Richard B Cole
Journal:  J Am Soc Mass Spectrom       Date:  2016-05-03       Impact factor: 3.109

9.  The suitability of different DHB isomers as matrices for the MALDI-TOF MS analysis of phospholipids: which isomer for what purpose?

Authors:  Jürgen Schiller; Rosmarie Süss; Beate Fuchs; Matthias Müller; Marijana Petković; Olaf Zschörnig; Hanka Waschipky
Journal:  Eur Biophys J       Date:  2006-09-20       Impact factor: 2.095

10.  HPLC-UV, MALDI-TOF-MS and ESI-MS/MS analysis of the mechlorethamine DNA crosslink at a cytosine-cytosine mismatch pair.

Authors:  Pornchai Rojsitthisak; Nutthapon Jongaroonngamsang; Rebecca M Romero; Ian S Haworth
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.